Trastuzumab Deruxtecan
ATC L01FD04 · 10 markets · 14 records
Trastuzumab Deruxtecan
Forms
AU 3 records · 2 strengths
- 100 mginjectionEnhertuENHERTU trastuzumab deruxtecan 100 mg powder for injection vial
Records without a stated strength · 1 Enhertu
ES 3 records · 1 strengths
- 100 mginjectionEnhertu
US 1 records · 1 strengths
- 100 mg/5 mLinjectionEnhertu
GB 1 records · 1 strengths
- 100 mginjectionEnhertu 100mg powder for concentrate for solution for infusion vials
CA 1 records · 1 strengths
- 100 mgpowderEnhertu
SG 1 records · 1 strengths
- 100 mg/vialinjectionENHERTU POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL
MX 1 records · 1 strengths
Records without a stated strength · 1 Enhertu
TW 1 records · 1 strengths
- 100 mginjectionENHERTU 100 mg powder for concentrate for solution for infusion優赫得凍晶注射劑100毫克
HK 1 records · 1 strengths
Records without a stated strength · 1 ENHERTU 100 mg powder for concentrate for solution for infusion
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Enhertu
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.